The global stereotactic surgery devices market is set to experience steady growth, with an expected market value of US$ 26.34 billion in 2023. According to recent market analysis, this figure is projected to rise to approximately US$ 39.36 billion by 2033, achieving a compound annual growth rate (CAGR) of 4.1% during the forecast period.
This growth is driven by increasing applications of stereotactic surgery in neurosurgery, oncology, and pain management, alongside advancements in imaging technologies and surgical precision. Stereotactic devices offer minimally invasive options for treating various conditions, enhancing patient outcomes and reducing recovery times.
As healthcare providers continue to prioritize innovative solutions for complex surgical procedures, the demand for advanced stereotactic surgery devices is expected to rise, further contributing to market expansion.
Disease Prevalence is Increasing as a Result of Changing Lifestyles
The products and solutions provided by the worldwide stereotactic surgery devices market manufacturers and participants enable surgical procedures such as biopsy, injection, implantation, radiosurgery, ablation, lesion, and stimulation. Because of the non-invasive or minimally invasive nature of the surgical operations offered by these solutions, items in the worldwide stereotactic surgery devices market are in high demand among medical professionals all over the world.
Proton beam, gamma knife, and LINAC or line accelerator machines are the most important types of equipment offered by manufacturers and sellers in the landscape of the worldwide stereotactic surgery devices market. Among the key applications for these items in the worldwide stereotactic surgery devices market are the treatment of arteriovenous malformations, epilepsy, trigeminal neuralgia, brain tumour treatment, and Parkinson’s disease.
Competitive Landscape
The leading manufacturers in the stereotactic surgery devices sector are working on various strategic efforts such as alliances, acquisitions, and growth to increase their market share. Partnerships and collaborations are also being leveraged by key players to improve their product and service offerings.
Elekta, for example, extended its relationship with Philips in June 2021 to shorten the route from cancer diagnosis to survivorship for improved outcomes. Key players are also attempting to maintain their market dominance by launching technologically advanced items. Elekta acquired a CE mark for their new radiosurgery system, Elekta Esprit, in November 2022.
Among the Key Companies in the Global Stereotactic Surgery Instruments Market are
- Koninklijke Philips N.V.
- Hitachi Medical Systems
- Huiheng Group
- Siemens Ag
- Elekta AB
- Varian Medical Systems
- IBA
- Accuray Incorporated
Key Companies Profiled
Koninklijke Philips N.V.; Hitachi Medical Systems; Huiheng Group; Siemens Ag; Elekta AB; Varian Medical Systems; IBA; Accuray Incorporated
Stereotactic Surgery Devices Market Key Segmentation
Stereotactic Surgery Devices Market by Product:
- Stereotactic surgery devices market for Gamma Knife
- Stereotactic surgery devices market for LINAC
- Stereotactic surgery devices market for PBRT
- Stereotactic surgery devices market for Cyber Knife
Stereotactic Surgery Devices Market by Application:
- Stereotactic surgery devices market for Liver
- Stereotactic surgery devices market for Breast
- Stereotactic surgery devices market for Prostate
- Stereotactic surgery devices market for Lung
- Stereotactic surgery devices market for Colon
Stereotactic Surgery Devices Market by Region:
- Stereotactic Surgery Devices in North America Market
- Stereotactic Surgery Devices in Europe Market
- Stereotactic Surgery Devices in Asia Pacific Market
- Stereotactic Surgery Devices in Latin America Market
- Stereotactic Surgery Devices in the Middle East & Africa Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
